Sunil Badve

  • 14825 Citations
  • 60 h-Index
1990 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 10 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Breast Medicine & Life Sciences
Estrogen Receptors Medicine & Life Sciences
Thymoma Medicine & Life Sciences
Carcinoma, Intraductal, Noninfiltrating Medicine & Life Sciences
Recurrence Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Publications 1990 2019

Association of Magnetic Resonance Imaging and a 12-Gene Expression Assay with Breast Ductal Carcinoma in Situ Treatment

Lehman, C. D., Gatsonis, C., Romanoff, J., Khan, S. A., Carlos, R., Solin, L. J., Badve, S., McCaskill-Stevens, W., Corsetti, R. L., Rahbar, H., Spell, D. W., Blankstein, K. B., Han, L. K., Sabol, J. L., Bumberry, J. R., Gareen, I., Snyder, B. S., Wagner, L. I., Miller, K., Sparano, J. A. & 1 othersComstock, C., Jan 1 2019, (Accepted/In press) In : JAMA Oncology.

Research output: Contribution to journalArticle

Carcinoma, Intraductal, Noninfiltrating
Magnetic Resonance Imaging
Gene Expression
Mastectomy
Radiotherapy

EarlyR signature predicts response to neoadjuvant chemotherapy in breast cancer

Buechler, S. A., Gökmen-Polar, Y. & Badve, S., Feb 1 2019, In : Breast. 43, p. 74-80 7 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Drug Therapy
Hormones
Adjuvant Chemotherapy
Survival

Splicing factor ESRP1 controls ER-positive breast cancer by altering metabolic pathways

Polar, Y., Neelamraju, Y., Goswami, C. P., Gu, Y., Gu, X., Nallamothu, G., Vieth, E., Janga, S. C., Ryan, M. & Badve, S., Feb 1 2019, In : EMBO Reports. 20, 2, e46078.

Research output: Contribution to journalArticle

Tamoxifen
Metabolic Networks and Pathways
Epithelial-Mesenchymal Transition
Tumors
Phosphoglycerate Dehydrogenase
67 Citations

Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer

Sparano, J. A., Gray, R. J., Makower, D. F., Pritchard, K. I., Albain, K. S., Hayes, D. F., Geyer, C. E., Dees, E. C., Goetz, M. P., Olson, J. A., Lively, T., Badve, S., Saphner, T. J., Wagner, L. I., Whelan, T. J., Ellis, M. J., Paik, S., Wood, W. C., Ravdin, P. M., Keane, M. M. & 10 othersGomez Moreno, H. L., Reddy, P. S., Goggins, T. F., Mayer, I. A., Brufsky, A. M., Toppmeyer, D. L., Kaklamani, V. G., Berenberg, J. L., Abrams, J. & Sledge, G. W., Jul 12 2018, In : New England Journal of Medicine. 379, 2, p. 111-121 11 p.

Research output: Contribution to journalArticle

Adjuvant Chemotherapy
Breast Neoplasms
Gene Expression
Recurrence
Drug Therapy
1 Citations

EarlyR: A Robust Gene Expression Signature for Predicting Outcomes of Estrogen Receptor–Positive Breast Cancer

Buechler, S. A., Polar, Y. & Badve, S., Jan 1 2018, (Accepted/In press) In : Clinical Breast Cancer.

Research output: Contribution to journalArticle

Transcriptome
Estrogen Receptors
Breast Neoplasms
Recurrence
Drug Therapy